Qiagen N.V.
QGENNYSEHealthcare● Active
$36.53
$-0.16(-0.42%)
Market Cap$7.5B
P/E Ratio—
52W High$57.82
52W Low$32.53
Qiagen N.V. (QGEN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · QGEN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.09B | $1.98B | $1.97B | $2.14B | $2.25B |
| Cost of Revenue | $0.80B | $1.01B | $0.73B | $0.76B | $0.80B |
| Gross Profit | $1.29B | $0.97B | $1.23B | $1.38B | $1.45B |
| Gross Margin %(computed) | 61.79% | 48.90% | 62.77% | 64.65% | 64.43% |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.19B | $0.20B | $0.19B | $0.19B |
| G&A Expenses | $0.13B | $0.11B | $0.12B | $0.13B | $0.13B |
| Total Operating Expenses | $0.77B | $0.87B | $0.82B | $0.85B | $0.82B |
| Operating Income | $0.52B | $0.10B | $0.41B | $0.53B | $0.63B |
| Operating Margin %(computed) | 24.90% | 4.94% | 20.86% | 24.82% | 27.98% |
| Interest Income | $0.06B | $0.07B | $0.08B | $0.03B | $0.01B |
| Interest Expense | $0.03B | $0.04B | $0.05B | $0.06B | $0.05B |
| Income Before Tax | $0.49B | $0.12B | $0.43B | $0.51B | $0.63B |
| Income Tax Expense | $0.07B | $0.04B | $0.09B | $0.09B | $0.11B |
| Net Income | $0.42B | $0.08B | $0.34B | $0.42B | $0.51B |
| Net Margin %(computed) | 20.33% | 4.23% | 17.37% | 19.76% | 22.77% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.04 | $0.39 | $1.67 | $2.08 | $2.52 |
| Wtd Avg Shares | 0.21B | 0.22B | 0.22B | 0.22B | 0.22B |
| EBITDA | $0.72B | $0.37B | $0.69B | $0.78B | $0.90B |
| EBITDA Margin %(computed) | 34.32% | 18.62% | 35.04% | 36.39% | 39.76% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Qiagen N.V. data
About Qiagen N.V. (QGEN) Income Statement
Qiagen N.V. (QGEN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, QGEN reported revenue of $2.09B, gross profit of $1.29B (gross margin 61.79%), and net income of $0.42B — a net profit margin of 20.33%.
Frequently asked questions
QGEN · 4 questionsQiagen N.V. (QGEN) reported revenue of $2.09B for 2025, up 5.7% year-over-year.
QGEN revenueQGEN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08